Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.56 USD | -1.51% | -12.98% | +8.06% |
Apr. 22 | Vanda Pharmaceuticals Appeal for Patents on Sleep Drug Declined by US Supreme Court | MT |
Apr. 22 | U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents | RE |
Chart calendar Vanda Pharmaceuticals Inc.
Upcoming events on Vanda Pharmaceuticals Inc.
Past events on Vanda Pharmaceuticals Inc.
2024-02-07 04:30 pm | Q4 2023 Earnings Call |
2024-02-07 04:02 pm | Q4 2023 Earnings Release |
2024-01-09 12:45 pm | JPMorgan Healthcare Conference |
2023-11-16 09:00 am | Jefferies London Healthcare Conference |
2023-11-14 04:10 pm | Stifel Healthcare Conference |
2023-11-08 04:30 pm | Q3 2023 Earnings Call |
2023-11-08 04:01 pm | Q3 2023 Earnings Release |
2023-10-11 01:25 pm | Jefferies Inaugural Biotech CNS/Neuro Summit |
2023-09-13 04:00 pm | H.C. Wainwright Global Investment Conference |
2023-07-27 04:30 pm | Q2 2023 Earnings Call |
2023-07-26 | Q2 2023 Earnings Release After hours |
2023-06-09 12:15 pm | Jefferies Global Healthcare Conference |
2023-06-08 09:00 am | Annual General Meeting |
2023-05-03 04:30 pm | Q1 2023 Earnings Call |
2023-05-03 04:01 pm | Q1 2023 Earnings Release |
2023-02-08 04:30 pm | FY 2022 Earnings Call |
2023-02-08 04:01 pm | FY 2022 Earnings Release |
2023-01-12 03:00 pm | JP Morgan Healthcare Conference |
2022-11-17 07:20 am | Jefferies London Healthcare Conference |
2022-11-15 10:20 am | Stifel Healthcare Conference |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 227 226 0.61% | 248 245 1.5% | 269 271 -0.75% | 254 258 -1.21% | 193 184 4.47% |
EBITDA Million USD | Released Forecast Spread | 39,2 27,8 40.86% | 0,00 0,00 - | 45,0 45,5 -1.04% | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | 22,8 32,3 -29.38% | 27,2 24,2 12.56% | 42,2 40,4 4.45% | 6,33 5,50 15.07% | -14,0 -18,4 24.17% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 29,0 33,9 -14.37% | 31,7 25,9 22.22% | 42,4 40,3 5.12% | 11,3 6,20 82.26% | 6,34 2,60 143.81% |
Net income Million USD | Released Forecast Spread | 116 121 -4.74% | 23,3 24,1 -3.17% | 33,2 31,1 6.58% | 6,28 2,70 132.41% | 2,51 -0,50 601.8% |
EPS USD | Released Forecast Spread | 2,11 2,17 -2.76% | 0,42 0,46 -7.74% | 0,58 0,54 8.41% | 0,11 0,04 175% | 0,04 -0,01 500% |
Announcement Date | 25/02/20 | 10/02/21 | 23/02/22 | 08/02/23 | 07/02/24 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 68,0 70,0 -2.88% | 60,2 58,0 3.78% | 64,4 67,0 -3.9% | 65,3 71,0 -8% | 64,5 67,6 -4.61% | 46,1 49,0 -6.01% | 38,8 44,5 -12.78% | 45,3 37,0 22.35% |
EBITDA Million USD | Released Forecast Spread | 9,34 9,28 0.72% | |||||||
EBIT Million USD | Released Forecast Spread | 8,64 6,65 29.8% | -7,67 -0,60 -1178.17% | 3,46 9,70 -64.32% | 3,91 6,60 -40.79% | 6,63 5,80 14.29% | -2,87 -9,40 69.5% | -6,00 -2,60 -130.58% | -7,09 -11,5 38.31% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 8,61 6,20 38.87% | -7,56 -0,60 -1160.67% | 3,79 9,70 -60.93% | 5,46 6,90 -20.86% | 9,61 6,10 57.59% | 2,59 -9,40 127.57% | -0,12 -2,60 95.38% | -1,66 -5,40 69.24% |
Net income Million USD | Released Forecast Spread | 7,08 4,87 45.42% | -6,43 -0,50 -1186% | 2,57 7,70 -66.57% | 3,27 5,40 -39.44% | 6,86 4,80 42.94% | 1,52 -7,50 120.27% | 0,14 -2,60 105.27% | -2,40 -5,40 55.56% |
EPS USD | Released Forecast Spread | 0,12 0,09 41.18% | -0,11 -0,01 -1000% | 0,05 0,12 -58.33% | 0,06 0,09 -33.33% | 0,12 0,08 50% | 0,03 -0,13 123.08% | 0,00 -0,04 - | -0,04 -0,09 55.56% |
Announcement Date | 23/02/22 | 05/05/22 | 03/08/22 | 02/11/22 | 08/02/23 | 27/07/23 | 08/11/23 | 07/02/24 |
Past sector events for Vanda Pharmaceuticals Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VNDA Stock
- Calendar Vanda Pharmaceuticals Inc.